By Fineline Cube 
China’s Ministry of Finance (MoF) has issued the “Notice on Implementing Relevant Measures for EU-Imported Medical Devices in Government Procurement Activities”. The notice stipulates that for medical device procurement projects with budgets exceeding RMB 45 million (USD 6.2 million), EU-based companies (excluding European-funded enterprises in China) must be excluded after completing required procedures if imported products are deemed necessary. Non-EU suppliers participating in such tenders must ensure that EU-imported medical devices do not exceed 50% of the total contract value. These restrictions do not apply where only EU-imported devices can meet procurement needs. The measures took effect immediately from July 6, 2025.
Policy Background
This policy is a countermeasure against the European Commission’s restrictions on Chinese companies and products in its medical device public procurement. Last month, the EU introduced measures limiting Chinese firms’ participation in its medical device tenders, further erecting trade barriers against Chinese enterprises. China has repeatedly expressed its willingness to resolve differences through bilateral dialogue and government procurement agreements.
China’s Position
Despite China’s goodwill and sincere efforts to engage in dialogue, the EU has persisted with protectionist restrictions. This has left China no choice but to adopt reciprocal measures. The restricted medical devices include surgical equipment, general diagnostic instruments, and blood products.-Fineline Info & Tech